Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Rico-Fontalvo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Case Reports in Nephrology|May 22, 2024
The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature ReviewCristian Betancur Henao, Juan Guillermo Rifaldo, Rafael Vicente-Pérez, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Mechanisms of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca, Jose Cabrales, et al.
International Journal of Molecular Sciences|July 29, 2025
Obesity-Related Kidney Disease: A Growing Threat to Renal HealthJuan León-Román, Marina López-Martínez, Alexandra Esteves, et al.
Case Reports in Nephrology|April 18, 2024
TINU: A Multisystemic Inflammatory Disorder-Case Report and Literature ReviewJuan Montejo-Hernández, Jorge Rico-Fontalvo, Jose Cabrales, et al.
Cureus|September 1, 2022
When to Use Antibiotics in COVID-19: A Proposal Based on QuestionsCarmelo Dueñas-Castell, Camilo Jose Polanco-Guerra, Maria Cristina Martinez-Ávila, et al.
Archivos De Cardiologia De Mexico|July 1, 2026
[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine]Rodrigo Daza-Arnedo, Carlos M Restrepo, Diego Araiza-Garaygordobil, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 27, 2026
Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver DysfunctionJorge Rico Fontalvo, Rodrigo Daza Arnedo, María Raad Sarabia, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 23, 2024
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the ArtDavid Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, et al.
Jornal Brasileiro De Nefrologia|November 8, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspectiveJorge Rico-Fontalvo, Maricely Reina, María José Soler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping ReviewJorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Case Reports in Nephrology|May 22, 2024
The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature ReviewCristian Betancur Henao, Juan Guillermo Rifaldo, Rafael Vicente-Pérez, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Mechanisms of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca, Jose Cabrales, et al.
International Journal of Molecular Sciences|July 29, 2025
Obesity-Related Kidney Disease: A Growing Threat to Renal HealthJuan León-Román, Marina López-Martínez, Alexandra Esteves, et al.
Case Reports in Nephrology|April 18, 2024
TINU: A Multisystemic Inflammatory Disorder-Case Report and Literature ReviewJuan Montejo-Hernández, Jorge Rico-Fontalvo, Jose Cabrales, et al.
Cureus|September 1, 2022
When to Use Antibiotics in COVID-19: A Proposal Based on QuestionsCarmelo Dueñas-Castell, Camilo Jose Polanco-Guerra, Maria Cristina Martinez-Ávila, et al.
Archivos De Cardiologia De Mexico|July 1, 2026
[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine]Rodrigo Daza-Arnedo, Carlos M Restrepo, Diego Araiza-Garaygordobil, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 27, 2026
Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver DysfunctionJorge Rico Fontalvo, Rodrigo Daza Arnedo, María Raad Sarabia, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 23, 2024
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the ArtDavid Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, et al.
Jornal Brasileiro De Nefrologia|November 8, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspectiveJorge Rico-Fontalvo, Maricely Reina, María José Soler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping ReviewJorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert, et al.
Pageof 3